Exponent, Inc. (NASDAQ:EXPO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “

Separately, Cantor Fitzgerald set a $64.00 price target on shares of Exponent and gave the stock a “buy” rating in a research report on Thursday, February 2nd.



Shares of Exponent (NASDAQ:EXPO) opened at 61.00 on Wednesday. Exponent has a 52 week low of $45.00 and a 52 week high of $64.80. The stock has a 50 day moving average of $58.73 and a 200-day moving average of $58.20. The company has a market capitalization of $1.56 billion, a price-to-earnings ratio of 34.86 and a beta of 0.63.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Wednesday, April 19th. The business services provider reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.48 by $0.09. Exponent had a return on equity of 15.76% and a net margin of 15.07%. The business had revenue of $80.47 million for the quarter, compared to analysts’ expectations of $79.32 million. During the same period in the prior year, the business posted $0.56 earnings per share. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. On average, analysts anticipate that Exponent will post $1.78 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 23rd. Stockholders of record on Friday, June 9th will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Wednesday, June 7th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.38%. Exponent’s payout ratio is 41.14%.

TRADEMARK VIOLATION NOTICE: “Exponent, Inc. (EXPO) Rating Lowered to Hold at Zacks Investment Research” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/04/21/exponent-inc-expo-rating-lowered-to-hold-at-zacks-investment-research.html.

Several large investors have recently modified their holdings of the company. State of Alaska Department of Revenue boosted its stake in shares of Exponent by 0.7% in the first quarter. State of Alaska Department of Revenue now owns 2,830 shares of the business services provider’s stock worth $168,000 after buying an additional 20 shares during the last quarter. Conestoga Capital Advisors LLC boosted its stake in shares of Exponent by 7.5% in the first quarter. Conestoga Capital Advisors LLC now owns 628,897 shares of the business services provider’s stock worth $37,451,000 after buying an additional 43,615 shares during the last quarter. Louisiana State Employees Retirement System boosted its stake in shares of Exponent by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 10,400 shares of the business services provider’s stock worth $619,000 after buying an additional 100 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Exponent by 21.8% in the first quarter. Bank of Montreal Can now owns 3,209 shares of the business services provider’s stock worth $192,000 after buying an additional 575 shares during the last quarter. Finally, Confluence Investment Management LLC boosted its stake in shares of Exponent by 10.0% in the first quarter. Confluence Investment Management LLC now owns 43,736 shares of the business services provider’s stock worth $2,605,000 after buying an additional 3,971 shares during the last quarter. 94.94% of the stock is currently owned by institutional investors and hedge funds.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

5 Day Chart for NASDAQ:EXPO

Receive News & Stock Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related stocks with our FREE daily email newsletter.